Liminatus Pharma, Inc. Class A Common Stock

LIMN us
$4.20
▲ +0.01 (+0.36%)
Volume: 15,648 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 45
  • 21d momentum -4.9%
  • RSI 51
🎯 Pullback 38
  • Near upper Bollinger band
  • +12.5% vs 20MA
💎 Value 58
  • -97% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)50.5
MACD+0.156
MA trendMixed
ATR9.78%
21d mom.-4.9%
63d mom.-20.6%
vs 20MA+12.5%
RVOL(20)0.51×
52w low · 3 52w high · 142
-97.0% from 52-week high
20d support 3 · resistance 5

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap—
PER—
PBR—
PSR—
EPS—
ROE—
ROA—
Dividend yield—
Debt/Equity—
EV/EBITDA—
week1M3M6M1YYTD
+20.55% -4.88% -20.62% -57.00% -94.13% -86.90%

Valuation and profitability in USD. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
8/10
🐻 Bear
4/10

14d momentum +13.07%, daily vol 5.28%. Liminatus Pharma, Inc. Class A Common Stock sits in a bullish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.